Emily Wheeler

PNW native, East Africa raised & DC living. @ElliottSchoolGW grad - Infectious Disease Policy Director at BIO. Travel, live music & food/bev enthusiast

[Biotechnology Innovation Organization @IAmBiotech]

New @PharmaMfg article explores the #antibiotics market. BIO’s @EmilyyWheelerr says “the #antimicrobial ecosystem really is fragile and frankly, failing due to
factors that are unique and make the sector completely different than other
areas of medicine.” https://t.co/432ojBIkIy

[Biotechnology Innovation Organization @IAmBiotech]

How do we fund the next novel #antibiotic? @EmilyyWheelerr @DavidThomasCFA @Merck @AMRActionFund @Spero_Tx discuss the antibiotic pipeline, funding challenges, and policy recommendations to support the development of new treatments now at #BIOCEO22: https://t.co/OJz1FwkVJW

[Biotechnology Innovation Organization @IAmBiotech]

Already, 700,000 die from drug-resistant infections each year worldwide—and without action, #AntimicrobialResistance could be the next pandemic. As we start World Antimicrobial Awareness Week, we explore the problem and possible solutions. #WAAW #AMR https://t.co/FihioDqfaV

[Antimicrobials Working Group @AWG_News]

Tune in tomorrow, Feb. 26 at 10:40 AM, to hear AWG's @EmilyyWheelerr present on the broken #antimicrobials system as part of #PACCARB's Innovation in an Era of Stewardship panel. Watch here: https://t.co/4DYzhorYQk

[Antimicrobials Working Group @AWG_News]

Emily Wheeler (AWG) joined @sarahdespres (@pewtrusts), and Greg Frank (@IamBiotech) for a panel discussion on advancing antimicrobial incentives moderated by Amanda Jezek (@IDSAinfo) at today's S-FAR Annual Meeting.